High Tower Advisors, LLC Intellia Therapeutics, Inc. Transaction History

High Tower Advisors, LLC

  • $68.3 Billion
  • Q3 2024

A detailed history of High Tower Advisors, LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 20,278 shares of NTLA stock, worth $289,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,278
Previous 23,245 12.76%
Holding current value
$289,975
Previous $520,000 20.0%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$19.72 - $27.36 $58,509 - $81,177
-2,967 Reduced 12.76%
20,278 $416,000
Q2 2024

Aug 13, 2024
SELL
$20.02 - $27.22 $2,262 - $3,075
-113 Reduced 0.48%
23,245 $520,000
Q1 2024

May 06, 2024
SELL
$23.82 - $32.8 $10,456 - $14,399
-439 Reduced 1.84%
23,358 $642,000
Q4 2023

Feb 12, 2024
SELL
$23.16 - $32.34 $41,271 - $57,629
-1,782 Reduced 6.97%
23,797 $725,000
Q3 2023

Nov 08, 2023
SELL
$31.62 - $45.78 $74,623 - $108,040
-2,360 Reduced 8.45%
25,579 $808,000
Q2 2023

Aug 14, 2023
SELL
$34.58 - $46.03 $14,765 - $19,654
-427 Reduced 1.51%
27,939 $1.14 Million
Q1 2023

May 11, 2023
BUY
$33.3 - $44.82 $75,890 - $102,144
2,279 Added 8.74%
28,366 $1.06 Million
Q4 2022

Feb 08, 2023
SELL
$33.21 - $62.69 $56,722 - $107,074
-1,708 Reduced 6.14%
26,087 $910,000
Q3 2022

Nov 09, 2022
BUY
$53.92 - $71.7 $6,039 - $8,030
112 Added 0.4%
27,795 $1.56 Million
Q2 2022

Aug 10, 2022
SELL
$38.49 - $76.21 $208,962 - $413,744
-5,429 Reduced 16.4%
27,683 $1.44 Million
Q1 2022

May 12, 2022
SELL
$58.27 - $118.99 $229,875 - $469,415
-3,945 Reduced 10.65%
33,112 $2.41 Million
Q4 2021

Feb 10, 2022
BUY
$100.76 - $138.36 $491,003 - $674,228
4,873 Added 15.14%
37,057 $4.38 Million
Q3 2021

Nov 12, 2021
BUY
$132.37 - $176.78 $484,474 - $647,014
3,660 Added 12.83%
32,184 $4.32 Million
Q2 2021

Aug 06, 2021
SELL
$60.88 - $161.91 $385,492 - $1.03 Million
-6,332 Reduced 18.17%
28,524 $4.62 Million
Q1 2021

May 10, 2021
BUY
$46.59 - $83.68 $247,113 - $443,838
5,304 Added 17.95%
34,856 $2.8 Million
Q4 2020

Feb 10, 2021
SELL
$18.83 - $63.53 $161,034 - $543,308
-8,552 Reduced 22.44%
29,552 $1.61 Million
Q3 2020

Nov 13, 2020
BUY
$17.47 - $24.93 $405,373 - $578,475
23,204 Added 155.73%
38,104 $756,000
Q2 2020

Aug 10, 2020
BUY
$11.14 - $22.87 $12,532 - $25,728
1,125 Added 8.17%
14,900 $314,000
Q1 2020

May 21, 2020
SELL
$9.44 - $15.58 $12,347 - $20,378
-1,308 Reduced 8.67%
13,775 $168,000
Q4 2019

Feb 14, 2020
SELL
$10.43 - $17.67 $23,384 - $39,616
-2,242 Reduced 12.94%
15,083 $219,000
Q3 2019

Nov 12, 2019
SELL
$13.07 - $18.51 $249,793 - $353,763
-19,112 Reduced 52.45%
17,325 $231,000
Q2 2019

Aug 13, 2019
BUY
$13.88 - $18.41 $25,344 - $33,616
1,826 Added 5.28%
36,437 $598,000
Q1 2019

May 15, 2019
BUY
$12.79 - $17.62 $254,329 - $350,373
19,885 Added 135.03%
34,611 $594,000
Q4 2018

Feb 14, 2019
BUY
$11.39 - $27.13 $24,089 - $57,379
2,115 Added 16.77%
14,726 $201,000
Q3 2018

Nov 09, 2018
BUY
$25.78 - $32.6 $112,014 - $141,647
4,345 Added 52.56%
12,611 $360,000
Q2 2018

Aug 14, 2018
BUY
$20.02 - $30.79 $165,485 - $254,510
8,266 New
8,266 $226,000
Q1 2018

May 15, 2018
SELL
$19.43 - $34.95 $295,336 - $531,240
-15,200 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$17.39 - $31.12 $264,328 - $473,024
15,200
15,200 $293,000

Others Institutions Holding NTLA

# of Institutions
313
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $1.09B
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email